(MENAFNEditorial) iCrowdNewswire - Nov 22, 2017
Global Antiretroviral Therapy Market 2017-2021
Antiretroviral therapy (ART) market is primarily related to the treatment of human immunodeficiency virus (HIV) infection. Antiretroviral drugs are usually taken in combination to prevent the growth of the virus, which slows the growth of HIV infection. The major drivers for the ART market include the rising awareness of retroviral infection, aggressive innovation in diagnostic techniques, the introduction of novel drugs through significant investments made in R & D, and high unmet needs in the retrovirus infection treatment domain
Analysts forecast the global to grow at a CAGR of 2.64% during the period 2017-2021.
Get Discount on this Report:
The top Key players are:
- Gilead
- ViiV Healthcare
- Janssen Pharmaceuticals
- Hoffmann-La Roche
- Abbvie
- Boehringer Ingelheim
- Bionor Pharma
- Vertex Pharmaceuticals
- Mylan
Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
Global Antiretroviral Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Market driver
- Rising awareness of retroviral infection
- For a full, detailed list, view our report
Segmentation:
Database and industry-specific repositories are used for defining the hypothesis for the study, which is further fine-tuned through primary research involving industry experts. The success of our approach lies in the fact that we take the viewpoint of all stakeholders into consideration while analyzing an industry, and objectively assess each outlook.
Get Sample Copy of this Report:
Table of Content:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
PART 05: DISEASE OVERVIEW
PART 06: MARKET LANDSCAPE
PART 07: PIPELINE LANDSCAPE
PART 08: MARKET SEGMENTATION BY DRUG CLASS
List of Exhibits
Exhibit 01: Global ART market
Exhibit 02: Global ART market 2016-2021 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Pipeline landscape by development phase
Exhibit 05: Key clinical trials
Exhibit 06: Global ART market by drug class 2016
Exhibit 07: Global ART market by drug class 2021
Exhibit 08: Global ART market by multiclass combination products 2016-2021 ($ millions)
Exhibit 09: Global ART market by NRTIs 2016-2021 ($ millions)
Exhibit 10: Global ART market by integrase inhibitors 2016-2021 ($ millions)
Exhibit 11: Global ART market by NNRTIs 2016-2021 ($ millions)
Exhibit 12: Global ART market by others 2016-2021 ($ millions)
Exhibit 13: Global ART market: Regional landscape
Exhibit 14: Regional comparison
Exhibit 15: ART market in Americas 2016-2021 ($ millions)
Continued @ ……………………………
Browse Complete report @
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report
The Green Suite #4594,
Dover, DE 19901
United States
Phone:1-201-355-0868
US Toll Free:1-866-764-2150
Email:
Website:
Contact Information:
The Green Suite #4594,
Dover, DE 19901
United States
Phone: 1-201-355-0868
US Toll Free: 1-866-764-2150
Email:
Website: https://www.marketstudyreport.com
News: https://www.marketstudyreport.com/category/news-releases/
MENAFN2211201700703403ID1096131395
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.